As of 2026-10-09, the Relative Valuation of XBiotech Inc (XBIT) is (29.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.20 USD, the upside of XBiotech Inc based on Relative Valuation is -1428.9%.
The range of the Relative Valuation is (22.20) - (32.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.0x - 21.8x | 19.4x |
| Forward P/E multiples | 12.9x - 26.0x | 20.0x |
| Fair Price | (22.20) - (32.33) | (29.24) |
| Upside | -1109.3% - -1569.5% | -1428.9% |
| Date | P/E |
| 2026-10-07 | -1.49 |
| 2026-10-06 | -1.46 |
| 2026-10-05 | -1.47 |
| 2026-10-02 | -1.48 |
| 2026-10-01 | -1.49 |
| 2026-09-30 | -1.48 |
| 2026-09-29 | -1.47 |
| 2026-09-28 | -1.45 |
| 2026-09-25 | -1.47 |
| 2026-09-24 | -1.46 |
| 2026-09-23 | -1.47 |
| 2026-09-22 | -1.47 |
| 2026-09-21 | -1.47 |
| 2026-09-18 | -1.48 |
| 2026-09-17 | -1.47 |
| 2026-09-16 | -1.45 |
| 2026-09-15 | -1.48 |
| 2026-09-14 | -1.47 |
| 2026-09-11 | -1.48 |
| 2026-09-10 | -1.47 |
| 2026-09-09 | -1.47 |
| 2026-09-08 | -1.47 |
| 2026-09-04 | -1.49 |
| 2026-09-03 | -1.49 |
| 2026-09-02 | -1.48 |
| 2026-09-01 | -1.50 |
| 2026-08-31 | -1.55 |
| 2026-08-28 | -1.53 |
| 2026-08-27 | -1.55 |
| 2026-08-26 | -1.56 |
| 2026-08-25 | -1.55 |
| 2026-08-24 | -1.56 |
| 2026-08-21 | -1.54 |
| 2026-08-20 | -1.56 |
| 2026-08-19 | -1.56 |
| 2026-08-18 | -1.53 |
| 2026-08-17 | -1.56 |
| 2026-08-14 | -1.55 |
| 2026-08-13 | -1.57 |
| 2026-08-12 | -1.66 |
| 2026-08-11 | -1.57 |
| 2026-08-10 | -1.54 |
| 2026-08-07 | -1.53 |
| 2026-08-06 | -1.54 |
| 2026-08-05 | -1.53 |
| 2026-08-04 | -1.51 |
| 2026-08-03 | -1.51 |
| 2026-07-31 | -1.51 |
| 2026-07-30 | -1.51 |
| 2026-07-29 | -1.52 |